Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 25 June, 2024|Author: Getaka | Social: X Twitter Profile
Stock Ticker - BSE: 531768 | NSE: POLYMED

Fundamental Analysis of Poly Medicure Ltd

Basic Stock Data

Last Updated: June 25, 2024, 10:26 pm

Market Cap 19,145 Cr.
Current Price 1,994
High / Low2,098/1,074
Stock P/E74.1
Book Value 153
Dividend Yield0.15 %
ROCE23.4 %
ROE19.0 %
Face Value 5.00
PEG Ratio3.72

Competitors of Poly Medicure Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Denis Chem Lab Ltd 277 Cr. 200233/86.124.8 57.91.00 %16.1 %11.3 % 10.0
Constronics Infra Ltd 50.2 Cr. 69.770.9/5.6569.8 1.350.00 %20.8 %118 % 10.0
Centenial Surgical Suture Ltd 41.5 Cr. 114160/61.436.7 88.30.00 %10.2 %3.57 % 10.0
Mohini Health & Hygiene Ltd 106 Cr. 58.197.0/46.59.86 55.10.00 %15.0 %12.0 % 10.0
Adeshwar Meditex Ltd 39.0 Cr. 27.036.0/18.319.4 24.20.00 %9.55 %6.11 % 10.0
Industry Average102.74 Cr93.7632.1145.370.20%14.33%30.20%10.00

Quarterly Result

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales204213212223230258249275285307321337340
Expenses146159157172179202202210214224234253249
Operating Profit58545551515646657183878490
OPM %28%25%26%23%22%22%19%24%25%27%27%25%27%
Other Income6811138859159141517
Interest5-230-111052223
Depreciation13131314141414141415161616
Profit before tax46525050464936596775838188
Tax %23%25%25%24%25%26%26%27%25%22%24%23%26%
Net Profit35393838353627445059636265
EPS in Rs4.004.053.923.993.603.772.814.545.216.136.546.486.78

Last Updated: June 11, 2024, 1:00 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 27, 2024, 1:43 am

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Sales2593223904114545196106877859221,1151,376
Expenses2062463043233613974795205697078471,018
Operating Profit5376868893122131166216215267358
OPM %20%24%22%21%21%23%22%24%28%23%24%26%
Other Income0112881416202122403861
Interest79101081214201161111
Depreciation131419212429374148545764
Profit before tax336385657597100126180195237344
Tax %30%30%27%27%27%27%35%24%25%25%25%25%
Net Profit2445624855716596136147179258
EPS in Rs2.755.117.075.476.258.007.4110.8614.1715.2818.6926.91
Dividend Payout %9%20%18%27%40%25%27%18%18%16%16%11%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)87.50%37.78%-22.58%14.58%29.09%-8.45%47.69%41.67%8.09%21.77%44.13%
Change in YoY Net Profit Growth (%)0.00%-49.72%-60.36%37.16%14.51%-37.54%56.14%-6.03%-33.58%13.68%22.37%

Growth

Compounded Sales Growth
10 Years:16%
5 Years:18%
3 Years:21%
TTM:23%
Compounded Profit Growth
10 Years:21%
5 Years:32%
3 Years:24%
TTM:50%
Stock Price CAGR
10 Years:32%
5 Years:61%
3 Years:26%
1 Year:76%
Return on Equity
10 Years:18%
5 Years:17%
3 Years:16%
Last Year:19%

Last Updated: June 25, 2024, 4:24 am

Poly Medicure Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital11112222224444444448484848
Reserves821011241742072272943373919181,0401,1941,290
Borrowings4649677982101133161207137127149135
Other Liabilities42537389768594112126121163187224
Total Liabilities1822142863643874575656547671,2241,3771,5771,697
Fixed Assets8592123165182207265306363426488635704
CWIP582010142018192521437896
Investments24344317825354346126165
Other Assets89110140185187227264321354422499738733
Total Assets1822142863643874575656547671,2241,3771,5771,697

Reserves and Borrowings Chart

Poly Medicure Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 33396663635675106128119123191
Cash from Investing Activity -26-31-58-59-31-56-88-101-107-436-85-179
Cash from Financing Activity -6-85-6-31-016-5-21317-35-13
Net Cash Flow0013-21031103-1

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow4.009.007.006.00-8.00-11.00-30.00-41.0079.0088.00118.00184.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days566152597477797768728277
Inventory Days145149142148114194161186241217218237
Days Payable96991011017613196123142111115105
Cash Conversion Cycle10611194106111140144139166179185209
Working Capital Days595631456581948373107116112
ROCE %30%27%33%30%26%24%26%22%25%22%17%18%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Promoters44.77%44.77%44.76%44.66%53.34%53.33%53.33%53.32%53.32%53.17%53.17%53.14%
FIIs12.82%13.68%14.13%15.07%15.59%16.27%16.33%16.21%15.61%14.49%14.10%12.37%
DIIs2.89%2.87%2.99%3.33%3.25%3.39%3.38%3.67%4.25%5.15%5.46%7.21%
Public39.52%38.68%38.11%36.94%27.82%27.02%26.97%26.79%26.82%27.20%27.28%27.25%
No. of Shareholders35,92233,67835,16633,83133,29634,23932,01535,39336,14134,64936,05336,712

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
UTI Flexi Cap Fund2,144,7731.24312.4249,7682024-06-234209.54%
Quant Small Cap Fund1,043,7520.97152.0449,7682024-06-231997.24%
UTI Unit Linked Insurance Plan (ULIP) - Fifteen Year Plan180,6090.526.3149,7682024-06-23262.9%
UTI Unit Linked Insurance Plan (ULIP) - Ten Year Plan180,6090.526.3149,7682024-06-23262.9%
WhiteOak Capital Flexi Cap Fund140,6380.6920.4949,7682024-06-23182.59%
Bank of India Small Cap Fund96,5001.5414.0649,7682024-06-2393.9%
UTI Healthcare Fund62,3280.999.0849,7682024-06-2325.24%
WhiteOak Capital Mid Cap Fund51,9060.497.5649,7682024-06-234.3%
Bank of India ELSS Tax Saver49,7680.667.2549,7682024-06-230%
Bank of India ELSS Tax Saver - Eco Plan49,7680.667.2549,7682024-06-230%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue5.005.005.005.005.00
Basic EPS (Rs.)26.9218.6915.2815.2510.86
Diluted EPS (Rs.)26.9018.6715.2715.2410.86
Cash EPS (Rs.)33.5724.4420.6518.7815.21
Book Value[Excl.RevalReserv]/Share (Rs.)153.18129.41113.40100.7149.27
Book Value[Incl.RevalReserv]/Share (Rs.)153.18129.41113.40100.7149.27
Revenue From Operations / Share (Rs.)143.35116.2496.2582.0377.88
PBDIT / Share (Rs.)43.4531.4326.1724.2820.67
PBIT / Share (Rs.)36.7925.4720.5519.3216.08
PBT / Share (Rs.)35.8724.5520.1018.4314.00
Net Profit / Share (Rs.)26.9118.4815.0213.8310.62
NP After MI And SOA / Share (Rs.)26.9118.6915.2814.1710.86
PBDIT Margin (%)30.3027.0427.1929.5926.54
PBIT Margin (%)25.6621.9121.3423.5520.64
PBT Margin (%)25.0221.1220.8822.4717.98
Net Profit Margin (%)18.7715.9015.6016.8513.63
NP After MI And SOA Margin (%)18.7716.0715.8717.2713.95
Return on Networth / Equity (%)17.5614.4313.4714.0722.04
Return on Capital Employeed (%)23.4219.0317.1317.6024.88
Return On Assets (%)13.8911.3610.6411.1012.49
Long Term Debt / Equity (X)0.000.010.030.060.25
Total Debt / Equity (X)0.110.110.110.100.38
Asset Turnover Ratio (%)0.800.730.680.760.92
Current Ratio (X)2.402.753.464.121.61
Quick Ratio (X)1.772.042.713.381.04
Inventory Turnover Ratio (X)2.162.252.392.222.24
Dividend Payout Ratio (NP) (%)0.0013.3716.360.0018.40
Dividend Payout Ratio (CP) (%)0.0010.1411.950.0012.93
Earning Retention Ratio (%)0.0086.6383.640.0081.60
Cash Earning Retention Ratio (%)0.0089.8688.050.0087.07
Interest Coverage Ratio (X)36.9034.1258.9927.359.96
Interest Coverage Ratio (Post Tax) (X)23.6321.0734.8616.576.12
Enterprise Value (Cr.)15271.329107.859208.877911.732221.33
EV / Net Operating Revenue (X)11.108.179.9810.063.23
EV / EBITDA (X)36.6230.2036.6933.9912.18
MarketCap / Net Operating Revenue (X)11.088.209.869.973.03
Retention Ratios (%)0.0086.6283.630.0081.59
Price / BV (X)10.377.368.378.124.78
Price / Net Operating Revenue (X)11.088.209.869.973.03
EarningsYield0.010.010.010.010.04

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value: 2,157.32

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 8.19% compared to the current price 1994

Intrinsic Value: 2,586.61

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 29.72% compared to the current price ₹1994

Last 5 Year EPS CAGR: 19.90%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 25.00%, which is a positive sign.
  2. The company has higher reserves (535.75 cr) compared to borrowings (122.17 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (446.75 cr) and profit (133.33 cr) over the years.
  1. The stock has a high average Working Capital Days of 76.83, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 140.83, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Poly Medicure Ltd:
    1. Net Profit Margin: 18.77%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 23.42% (Industry Average ROCE: %)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 17.56% (Industry Average ROE: %)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 23.63
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.77
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. ✗ Stock P/E: 74.1 (Industry average Stock P/E: )
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.11
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company

Poly Medicure Ltd. is a Public Limited Listed company incorporated on 30/03/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L40300DL1995PLC066923 and registration number is 066923. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 879.36 Cr. and Equity Capital is Rs. 47.95 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Medical Equipment & AccessoriesNo. 232-B, 3rd Floor, New Delhi Delhi 110020investorcare@polymedicure.com
http://www.polymedicure.com
Management
NamePosition Held
Mr. Devendra Raj MehtaChairman
Mr. Himanshu BaidManaging Director
Mr. Rishi BaidJoint Managing Director
Mr. Jugal Kishore BaidNon Executive Director
Mrs. Mukulika BaidNon Executive Director
Mr. Alessandro BalboniNon Executive Director
Mr. Prakash Chand SuranaInd. Non-Executive Director
Dr. Shailendra Raj MehtaInd. Non-Executive Director
Dr. Ambrish MithalInd. Non-Executive Director
Dr. Sandeep BhargavaInd. Non-Executive Director
Mr. Amit KhoslaInd. Non-Executive Director
Ms. Sonal MattooInd. Non-Executive Director

FAQ

What is the latest fair value of Poly Medicure Ltd?

The latest fair value of Poly Medicure Ltd is ₹2157.32.

What is the Market Cap of Poly Medicure Ltd?

The Market Cap of Poly Medicure Ltd is 19,145 Cr..

What is the current Stock Price of Poly Medicure Ltd as on 25 June 2024?

The current stock price of Poly Medicure Ltd as on 25 June 2024 is ₹1,994.

What is the High / Low of Poly Medicure Ltd stocks in FY 2024?

In FY 2024, the High / Low of Poly Medicure Ltd stocks is 2,098/1,074.

What is the Stock P/E of Poly Medicure Ltd?

The Stock P/E of Poly Medicure Ltd is 74.1.

What is the Book Value of Poly Medicure Ltd?

The Book Value of Poly Medicure Ltd is 153.

What is the Dividend Yield of Poly Medicure Ltd?

The Dividend Yield of Poly Medicure Ltd is 0.15 %.

What is the ROCE of Poly Medicure Ltd?

The ROCE of Poly Medicure Ltd is 23.4 %.

What is the ROE of Poly Medicure Ltd?

The ROE of Poly Medicure Ltd is 19.0 %.

What is the Face Value of Poly Medicure Ltd?

The Face Value of Poly Medicure Ltd is 5.00.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Poly Medicure Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE